McKesson stock trades at USD 902.28 after CVS deal

Published on 10/03/2026 at 22:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

McKesson stock gets a longer CVS distribution runway after the October 1, 2026 agreement. Fiscal 2027 adjusted EPS guidance stays at USD 44.20-45.00, while first-quarter revenue reached USD 105.38 billion.

Trader auf Börsenparkett vor Bildschirmen mit Kurscharts und Gesundheitsdaten — Börsen-Editorial-Foto vom Trading-Floor mit Charts symbolisiert Börsennotierung von McKesson Corporation ISIN US58155Q1031 an der NYSE, Illustration mit AI erstellt.

McKesson Corporation (ISIN US58155Q1031) was last at USD 902.28 on the NYSE on October 2, 2026 at 4:00 p.m. ET, up 0.38 percent from the prior close. The central development is a CVS distribution agreement extending through June 2032, while fiscal 2027 adjusted EPS guidance remains USD 44.20-45.00, according to StockTitan on October 1, 2026.

CVS agreement extends visibility

The agreement in principle covers mail-order, specialty and retail pharmacies, plus distribution centers. The company also reaffirmed its long-term adjusted EPS growth rate of 13 percent to 16 percent and scheduled its fiscal 2027 second-quarter earnings call for November 4, 2026, according to StockTitan.

The wording matters because the arrangement remains an agreement in principle. The company identified possible delays in signing a definitive contract and the realization of expected benefits as risks, keeping execution alongside revenue visibility in the investment case.

Revenue and EPS beat estimates

McKesson's fiscal 2027 first-quarter revenue was USD 105.38 billion, up 7.7 percent year over year, while adjusted EPS reached USD 9.93 versus USD 9.56 consensus. MarketBeat reported the figures in its September 13, 2026 company update.

The comparison is material: first-quarter adjusted EPS exceeded consensus by USD 0.37, while revenue exceeded the USD 103.88 billion estimate by USD 1.50 billion. That combination gives the renewed CVS relationship a stronger operating backdrop than a contract announcement alone.

Stock stays below yearly high

McKesson stock carried a market capitalization of USD 105.6 billion on October 2, 2026. Its 52-week range was USD 723.68-999, placing the last price USD 96.72 below the yearly high and USD 178.60 above the low.

Trading volume was 775,563 shares on the session, while the intraday range ran from USD 881.74 to USD 905.54. For investors, the November 4 earnings update is the next defined checkpoint for testing whether the guidance reaffirmation and CVS extension are translating into continued execution.